CA
NZ
UK
AU
IND
US
The stock was among the names that moved during the Monday November 2, 2026 session, but no company press release or regulatory filing dated November 2 or November 3, 2026 was identified. The decline may reflect continued trading in a thinly held stock after …
No company press release or regulatory filing dated between October 30 and November 3, 2026 was identified. The most recent company update found was dated September 8, 2026, so the move may reflect momentum or sector sentiment around obesity drug developers rather than new …
No separate company announcement dated November 2 or November 3, 2026 was identified. The split itself is the likely backdrop, since tiny share counts often produce sharp price swings.
We did not find a press release or regulatory filing from the company dated October 30 to November 3, 2026 that explains the move. With no identified catalyst, the decline looks more like routine trading in a small, thinly followed stock than a reaction …
The latest financial update came in an earnings release dated August 6, 2026, for the quarter ended June 30, 2026. Revenue was USD 11.4 million, up 1.7% from USD 11.2 million in the second quarter of 2025. Gross margin improved to 86.8% from 83.9%.
No company announcement dated between October 30 and November 3, 2026 was identified. Given the stock's recent history of sharp swings after its listing change, the move looks likeMomentum Tradingrather than a response to a disclosed event.
SurgePays, Inc. (NASDAQ:SURG) was up 8.57% to USD 0.1672 in pre-market trading on November 3, 2026, against the Monday, November 2, 2026 close. A search of company press releases and regulatory filings found no announcement dated between October 30 and November 3, 2026 that …
No company announcement dated November 2 or November 3 was identified. The move follows a late October disclosure of the merger closing and its financing terms, which reshaped what common shareholders own.
The company filed a Form S-1 dated November 2, 2026. The terms of that filing were not identified, so the catalyst is only partly clear. Market data indicated the shares had jumped intraday on Monday, which suggests Tuesday is aReversalof that spike.
No company announcement dated November 2 or November 3 was identified. The stock was also sharply lower in the Monday session, so the pre-market decline continues a multi-day slide that began after theMergerterm sheet.
Please wait processing your request...